April 2019 FDA Recall Drug by Remedyrepack Inc.
D-1270-2019 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Remedyrepack Inc. on April 22, 2019 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in Product was distributed to Florida. and the recall is currently terminated.

Recall Number: D-1270-2019

Reason for Recall
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level of 0.96 parts per million.
Initiated
04-22-2019
Reported
05-08-2019
Quantity
44 HDPE bottles of 90 = 3,960 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Product was distributed to Florida.
Losartan Potassium/HCTZ, 100 mg/12.5 mg Tablet, 90-Count bottle, Manufactured by Torrent Pharmaceuticals, Distributed by RemedyRepack, Inc. Indiana, PA, 15701-3570, NDC 70518-1560-00.

Batch or Lot Expiration Information

Lot# : B0517068-101618, Exp. Date: 10/2019